Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-1,075
Closed -$15.7K 942
2026
Q1
$15.7K Hold
1,075
﹤0.01% 580
2025
Q4
$13.6K Hold
1,075
﹤0.01% 589
2025
Q3
$16.5K Hold
1,075
﹤0.01% 565
2025
Q2
$16.9K Hold
1,075
﹤0.01% 560
2025
Q1
$20.5K Hold
1,075
0.01% 499
2024
Q4
$25.6K Hold
1,075
0.01% 472
2024
Q3
$30.1K Hold
1,075
0.01% 458
2024
Q2
$28.1K Hold
1,075
0.01% 444
2024
Q1
$23.5K Hold
1,075
0.01% 448
2023
Q4
$25K Hold
1,075
0.01% 436
2023
Q3
$21.2K Hold
1,075
0.01% 416
2023
Q2
$24.4K Hold
1,075
0.01% 393
2023
Q1
$21.1K Hold
1,075
0.01% 393
2022
Q4
$18.5K Buy
+1,075
New +$19.1K 0.01% 383

Other funds holding RXO

Addison Advisors's RXO Position: Q2 2026 in Review

Addison Advisors sold out of RXO (RXO) in Q2 2026, closing a stake of 1,075 shares — an estimated $15.7K sold.

Addison Advisors first reported a position in RXO in Q4 2022 and held it in 14 quarters. The position peaked at $30.1K in Q3 2024. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Addison Advisors reported no remaining RXO position as of Q2 2026 after selling out during the quarter.
  • Addison Advisors sold 1,075 RXO shares in Q2 2026, an estimated $15.7K.
  • Addison Advisors first reported a position in RXO in Q4 2022 and held it in 14 quarters.
  • Addison Advisors's RXO position peaked at $30.1K in Q3 2024.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Addison Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.